Sandostatin
OVERDOSE
No frank overdose has occurred in any patient to date. Intravenous bolus doses of 1 mg (1000 mcg) given to healthy volunteers and of 30 mg (30,000 mcg) IV over 20 minutes and of 120 mg (120,000 mcg) IV over 8 hours to research patients have not resulted in serious ill effects.
Up-to-date information about the treatment of overdose can often be obtained from a certified Regional Poison Control Center. Telephone numbers of certified Regional Poison Control Centers are listed in the Physician's Desk ReferenceÒ.*
Mortality occurred in mice and rats given 72 mg/kg and 18 mg/kg IV, respectively.
Drug Abuse and Dependence
There is no indication that SandostatinÒ (octreotide acetate) has potential for drug abuse or dependence. SandostatinÒ (octreotide acetate) levels in the central nervous system are negligible, even after doses up to 30,000 mcg.
CONTRAINDICATIONS
Sensitivity to this drug or any of its components.
Generic Name: Octreotide Acetate
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Cancer
Get the latest treatment options.
Cancer and Exercise
Resting to conserve energy may not be the best remedy for fatigue during radiation therapy. See more WebMD Videos »
Sandostatin
Health Resources
2008 Election & Health Care on WebMD. Get Informed.
Updated & New
RxList does not provide medical advice, diagnosis or treatment.